Valvular Heart Disease
The Valvular Heart Disease (VHD) Learning Pathway reflects the interdisciplinary team approach that is becoming prevalent in the treatment of patients with valvular heart disease due to more complex case scenarios and multiple comorbidities. VHD specialists, general cardiologists, other cardiovascular physician and non-physician providers, cardiothoracic surgeons, and other providers will find informative, interactive sessions that expand their understanding and knowledge of how to provide the highest level of care for a patient with valvular heart disease.
From general reviews to case-based sessions to a look into the future, many sessions provide practitioners with an overview of this rapidly changing field. During session #709 look at the exploding data on medium and long-term outcomes of TAVR as well as the increasing pressure to consider TAVR for intermediate (recently FDA approved) and low-risk patients (clinical trials). Session #779 takes on the important issue of lifelong tracking of all prosthetic valves, not just the already mandated tracking of TAVR. Presenters represent a wide variety of stakeholders in this issue, including an FDA representative and registries. Additional sessions on these topics include:
- Structural Heart Disease: Difficult Choices for the Heart Team (session #679)
- Focus on Structural and Valvular Heart Disease: Joint Symposium of the Association of Black Cardiologists and the American College of Cardiology (session #710)
- TAVR: What We’ve Learned and Where We Think We're Going! (session #709)
- Post FDA Release Prosthetic Valve Surveillance: Watching for Signals (session #779)
For hot topics, look no further than the ACC Guidelines for the Management of Patients with Valvular Heart Disease, which have introduced new concepts and criteria in disease management essential to the modern practice of cardiology. The sessions on valves focus on the changes and the knowledge gaps that the guidelines fill and feature presenters and panelists who are the actual guideline writers and experts in the field.
- Valvular Heart Disease Guidelines: The Evidence and the Gaps (session #663)
- Controversies in Mitral Valve Surgery: Joint Symposium of the Society of Thoracic Surgeons and the American College of Cardiology (session #738)
- Mitral Valve Guidelines: Closing Knowledge Gaps (session #764)
Join the experts and your colleagues for an exciting and informative open microphone session in the Engage@ACC.17 Studio for session #6001, Valvular Heart Disease Questions and Answers. Bring your actual case questions to ask the experts. Last year’s popular session was standing room only!
From basic science to clinical practice, medicine is always advancing. For informative reviews of significant research contributions, check out Innovations in Valvular Heart Disease Diagnosis and Treatment (session #695) and the annual Highlighted Original Research (session #912) which provide reviews of the role of bio-markers, three-dimensional imaging and printing, and the use of multimodality imaging tool bioengineering as well as other important research contributions.
The VHD program is packed with information for specialists and general practitioners, physician and non-physician providers, and while you’re at ACC.17, be sure to check other learning pathways, such as Interventional Cardiology, Non-Invasive Imaging and Congenital Heart Disease, for more information related to caring for patients with valvular heart disease.
| 2017 American College of Cardiology Foundation. Visit ACC.org|